RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: July 7, 2010
Last updated: November 6, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)